News
📈 Stocks
NAD Recommends Good Life Meds Halt Unsubstantiated Tirzepatide Claims
(just now)
BBB National Programs' NAD mandates that Good Life Meds cease unsupported advertising for its compounded Tirzepatide+ offerings following a formal challenge from…